Johnson & Johnson (JNJ) Liabilities and Shareholders Equity (2009 - 2026)
Johnson & Johnson (JNJ) posted Liabilities and Shareholders Equity of $201.06 billion for Q2 2026, up 4.0% from $193.39 billion a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Johnson & Johnson's Liabilities and Shareholders Equity came in at $199.21 billion, up 10.6% from FY2024.
- Annual Liabilities and Shareholders Equity shows a four-year compound annual growth rate of 3.3% (FY2021 to FY2025).
- In prior years, Johnson & Johnson's Liabilities and Shareholders Equity was $180.1 billion in FY2024 (+7.5%), $167.56 billion in FY2023 (-10.6%), $187.38 billion in FY2022 and $174.89 billion in FY2021.
- The Q2 2026 figure stands as the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2011.
- On a year-over-year basis, Liabilities and Shareholders Equity has increased in each of the last eight quarters, with growth averaging 7.6% over the last eight quarters.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q1 2025, with growth of 12.6%; the weakest was Q1 2024, with a decline of 12.2%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $200.89 billion (Q1 2026), $199.21 billion (Q4 2025) and $192.82 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 27.42 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 201.06 Bn |
| Mar 29, 2026 | 200.89 Bn |
| Dec 28, 2025 | 199.21 Bn |
| Sep 28, 2025 | 192.82 Bn |
| Jun 29, 2025 | 193.39 Bn |
| Mar 30, 2025 | 193.67 Bn |
| Dec 29, 2024 | 180.10 Bn |
| Sep 29, 2024 | 178.29 Bn |
| Jun 30, 2024 | 181.09 Bn |
| Mar 31, 2024 | 171.97 Bn |
| Dec 31, 2023 | 167.56 Bn |
| Oct 1, 2023 | 166.06 Bn |
| Jul 2, 2023 | 191.69 Bn |
| Apr 2, 2023 | 195.97 Bn |
| Jan 1, 2023 | 187.38 Bn |
| Oct 2, 2022 | 175.12 Bn |
| Jul 3, 2022 | 177.72 Bn |
| Apr 3, 2022 | 178.36 Bn |
| Jan 2, 2022 | 182.02 Bn |
| Oct 3, 2021 | 179.23 Bn |
API Access
Johnson & Johnson Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();